Compare ANF & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANF | MMSI |
|---|---|---|
| Founded | 1892 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 1996 | 1996 |
| Metric | ANF | MMSI |
|---|---|---|
| Price | $93.89 | $75.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $120.50 | $98.88 |
| AVG Volume (30 Days) | ★ 1.0M | 751.6K |
| Earning Date | 05-27-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | ★ 1.47 | 0.68 |
| Revenue | ★ $5,266,292,000.00 | $1,515,906,000.00 |
| Revenue This Year | $5.10 | $8.85 |
| Revenue Next Year | $3.83 | $5.88 |
| P/E Ratio | ★ $65.08 | $108.72 |
| Revenue Growth | 6.42 | ★ 11.75 |
| 52 Week Low | $65.45 | $59.74 |
| 52 Week High | $133.11 | $94.75 |
| Indicator | ANF | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 63.95 |
| Support Level | $91.48 | $66.19 |
| Resistance Level | $103.37 | $84.69 |
| Average True Range (ATR) | 3.96 | 2.17 |
| MACD | 0.22 | 0.22 |
| Stochastic Oscillator | 51.53 | 82.98 |
Abercrombie & Fitch Co is a digitally led, omnichannel retailer offering apparel, personal care products, and accessories for men, women, and kids through company-owned stores, digital channels, and third-party arrangements. The company operates through three geographic segments: Americas, the maximum revenue generator; Europe, the Middle East and Africa (EMEA); and Asia-Pacific (APAC). Its brand families include Abercrombie brands and Hollister brands. The Americas segment covers North and South America, EMEA includes Europe, the Middle East and Africa, and APAC includes the Asia-Pacific region, including Asia and Oceania.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.